BIGG

COVID-19 treatment guidelines panel: Coronavirus diseases 2019 (COVID-19) treatment guidelines

National Institutes of Health.

The COVID-19 Treatment Guidelines were developed to provide clinicians with guidance on caring for patients with COVID-19. Because clinical information about the optimal management of COVID-19 is evolving quickly, these Guidelines are updated frequently to reflect newly published data and other authorita...

Tratamiento Farmacológico de COVID-19, COVID-19/diagnóstico, Coronavirus Relacionado al Síndrome Respiratorio Agudo Severo/inmunología, Antivirales/uso terapéutico, Inmunoterapia, Corticoesteroides/uso terapéutico, Prueba Serológica para COVID-19, Suplementos Dietéticos

Texto completo

Pan-American Guidelines for the Treatment of SARS-CoV-2/COVID-19: a joint evidence-based guideline of the Brazilian Society of Infectious Diseases (SBI) and the Pan-American Association of Infectious Diseases (API) [Pré-print]

Barbosa, Alexandre Naime; Chebabo, Alberto; Pérez, Clevy; Cunha, Clóvis Arns; Luna, David de; Nunes, Estevão Portela; Zambrano, Gabriela; Ferreira, Juliana Carvalho; Croda, Júlio; Falavigna, Maicon; Silva, Monica Maria Gomes da; Cimerman, Sergio; Parahiba, Suena Medeiros; Tanni, Suzana; Bernardo, Wanderley Marques; Rodriguez-Morales, Alfonso J.

Since the beginning of the COVID-19 pandemic, therapeutic options for treating COVID-19 have been investigated at different stages of clinical manifestations. Considering the particular impact of COVID-19 in the Americas, this document aims to present recommendations for the pharmacological treatment of ...

COVID-19/tratamiento farmacológico, SARS-CoV-2/efectos de los fármacos, Antivirales/uso terapéutico, Anticuerpos Monoclonales/uso terapéutico, Hidroxicloroquina/uso terapéutico, Cloroquina/uso terapéutico

Texto completo (enlace principal) Texto completo (enlace alternativo)

Recommendations for screening, monitoring, prevention, prophylaxis and therapy of hepatitis B virus reactivation in patients with haematologic malignancies and patients who underwent haematologic stem cell transplantation-a position paper

Sarmati, L; Andreoni, M; Antonelli, G; Arcese, W; Bruno, R; Coppola, N; Gaeta, G. B; Galli, M; Girmenia, C; Mikulska, M; Pane, F; Perno, C. F; Picardi, M; Puoti, M; Rambaldi, A; Svicher, V; Taliani, G; Gentile, G.

Clin. microbiol. infect; 23 (12), 2017

SCOPE: Hepatitis B virus (HBV) infection reactivation is associated with high morbidity and mortality in patients with haematologic malignancy and/or haematopoietic stem cell transplantation (HSCT). However, information on this issue is limited. The scope of this position paper is to provide recommendati...

Trasplante de Células Madre Hematopoyéticas, Neoplasias Hematológicas/complicaciones, Hepatitis B/prevención & control, Antivirales/uso terapéutico, Activación Viral, Hepatitis B/diagnóstico, Hepatitis B/tratamiento farmacológico, Recurrencia

Texto completo